VRNA vs. ONC, INSM, BNTX, TEVA, GMAB, SMMT, ASND, RDY, VTRS, and ROIV
Should you be buying Verona Pharma PLC American Depositary Share stock or one of its competitors? The main competitors of Verona Pharma PLC American Depositary Share include BeOne Medicines (ONC), Insmed (INSM), BioNTech (BNTX), Teva Pharmaceutical Industries (TEVA), Genmab A/S (GMAB), Summit Therapeutics (SMMT), Ascendis Pharma A/S (ASND), Dr. Reddy's Laboratories (RDY), Viatris (VTRS), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry.
Verona Pharma PLC American Depositary Share vs. Its Competitors
BeOne Medicines (NASDAQ:ONC) and Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.
Verona Pharma PLC American Depositary Share has lower revenue, but higher earnings than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than Verona Pharma PLC American Depositary Share, indicating that it is currently the more affordable of the two stocks.
In the previous week, BeOne Medicines had 1 more articles in the media than Verona Pharma PLC American Depositary Share. MarketBeat recorded 8 mentions for BeOne Medicines and 7 mentions for Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share's average media sentiment score of 1.34 beat BeOne Medicines' score of 0.92 indicating that Verona Pharma PLC American Depositary Share is being referred to more favorably in the news media.
BeOne Medicines has a beta of 0.31, indicating that its stock price is 69% less volatile than the S&P 500. Comparatively, Verona Pharma PLC American Depositary Share has a beta of 0.05, indicating that its stock price is 95% less volatile than the S&P 500.
BeOne Medicines presently has a consensus target price of $336.30, indicating a potential downside of 1.56%. Verona Pharma PLC American Depositary Share has a consensus target price of $109.00, indicating a potential upside of 1.92%. Given Verona Pharma PLC American Depositary Share's higher probable upside, analysts plainly believe Verona Pharma PLC American Depositary Share is more favorable than BeOne Medicines.
48.6% of BeOne Medicines shares are held by institutional investors. Comparatively, 85.9% of Verona Pharma PLC American Depositary Share shares are held by institutional investors. 6.6% of BeOne Medicines shares are held by company insiders. Comparatively, 4.8% of Verona Pharma PLC American Depositary Share shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
BeOne Medicines has a net margin of -3.89% compared to Verona Pharma PLC American Depositary Share's net margin of -36.62%. BeOne Medicines' return on equity of -1.22% beat Verona Pharma PLC American Depositary Share's return on equity.
Summary
BeOne Medicines beats Verona Pharma PLC American Depositary Share on 10 of the 17 factors compared between the two stocks.
Get Verona Pharma PLC American Depositary Share News Delivered to You Automatically
Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding VRNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Verona Pharma PLC American Depositary Share Competitors List
Related Companies and Tools
This page (NASDAQ:VRNA) was last updated on 10/8/2025 by MarketBeat.com Staff
